Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Taisho to develop Tanabe MAO-A inhibitor

May 8, 1997

No Comments

Novo Nordisk describes heterocyclic compounds for neurogenic pain/inflammation

May 8, 1997

No Comments

ECE inhibitors from Santen

May 8, 1997

No Comments

FDA clears generic antidepressant from Teva

May 7, 1997

No Comments

Alniditan more effective than sumatriptan in animal model of migraine

May 7, 1997

No Comments

Riboflavin shows promise for migraine prophylaxis

May 7, 1997

No Comments

Population-based study of postmenopausal ERT and risk of AD

May 7, 1997

No Comments

Rotterdam study assesses risk factors for dementia and AD

May 7, 1997

No Comments

Warner-Lambert reveals agents with dual dopaminergic/serotonergic activity

May 7, 1997

No Comments

nAChR ligands prepared by Novo Nordisk

May 7, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Taisho to develop Tanabe MAO-A inhibitor

Novo Nordisk describes heterocyclic compounds for neurogenic pain/inflammation

ECE inhibitors from Santen

FDA clears generic antidepressant from Teva

Alniditan more effective than sumatriptan in animal model of migraine

Riboflavin shows promise for migraine prophylaxis

Population-based study of postmenopausal ERT and risk of AD

Rotterdam study assesses risk factors for dementia and AD

Warner-Lambert reveals agents with dual dopaminergic/serotonergic activity

nAChR ligands prepared by Novo Nordisk

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Neurology/psychiatric RSS

Neurology/psychiatric
RSS